Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dottie Horvath"'
Autor:
Mary Jane Staab, Harish Ahuja, Jules H. Blank, Rebecca Marnocha, Alcee Jumonville, Dottie Horvath, Dona Alberti, Jens C. Eickhoff, Jane Straus, Michael Eastman, Michael Glode, Douglas G. McNeel, Glenn Liu, Steven Attia, George Wilding, Daniel H. Shevrin
Publikováno v:
Clinical Cancer Research. 14:2437-2443
Purpose: Docetaxel is standard of care for androgen-independent prostate cancer (AIPC). Doxercalciferol (1α-hydroxyvitamin D2) had modest activity in phase I/II trials. Preclinical data support combining vitamin D analogues with docetaxel to treat A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8e0b04b2602d7cf4236f21702abe3e
https://doi.org/10.1158/1078-0432.ccr-07-4274
https://doi.org/10.1158/1078-0432.ccr-07-4274
Autor:
Rebecca Marnocha, Yulin Zhang, Michael S. Huie, George Wilding, Amy Drezen, Dona Alberti, Jeffrey A. Douglas, Lynn Van Ummersen, Dottie Horvath, Kurt R. Oettel, Mary Jane Staab, Mann Kim Kyung
Publikováno v:
Investigational New Drugs. 24:255-260
Objective: To assess the efficacy and toxicity of the combination of interferon-alpha and doxycycline in patients with metastatic renal cell carcinoma and to assess the effect of this treatment on serum vascular endothelial growth factor (VEGF) level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d921158fa3e7d2f078b5c62a44054047
https://doi.org/10.1007/s10637-005-3903-z
https://doi.org/10.1007/s10637-005-3903-z
Autor:
Michael Huie, Kurt Oettel, Lynn Van Ummersen, Kyung Kim, Yulin Zhang, Mary Staab, Dottie Horvath, Rebecca Marnocha, Jeff Douglas, Amy Drezen, Dona Alberti, George Wilding
Publikováno v:
Investigational New Drugs; May2006, Vol. 24 Issue 3, p255-260, 6p
Autor:
Thomas Frye, Douglas G. McNeel, Laura E. Johnson, George Wilding, Mary Jane Staab, Edward J. Dunphy, Jane Straus, Glenn Liu, D. Alberti, Dottie Horvath
Publikováno v:
Journal of Clinical Oncology. 24:14570-14570
14570 Background: Prostatic acid phosphatase (PAP) is a tumor antigen in prostate cancer. Clinical trials conducted in patients with metastatic prostate cancer targeting PAP by means of antigen presenting-cell vaccines have suggested clinical benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b7ea22b2aa9d3a4afa31dc2495bad73
https://doi.org/10.1200/jco.2006.24.18_suppl.14570
https://doi.org/10.1200/jco.2006.24.18_suppl.14570
Autor:
Kathy Schell, J. Eikhoff, M. Malkovsky, Dottie Horvath, George Wilding, Jane Straus, Mary Jane Staab, Douglas G. McNeel, Glenn Liu, M. Wallace
Publikováno v:
Journal of Clinical Oncology. 24:14607-14607
14607 Background: Approximately 3–6% of human peripheral blood lymphocytes express the γδ T cell receptor (TCR). The majority of these cells express the Vδ2 TCR variable segment associated with the Vγ9 segment. Vγ9Vδ2 T cells can recognize ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a086af94f38ad52f887cde18c13d9d3a
https://doi.org/10.1200/jco.2006.24.18_suppl.14607
https://doi.org/10.1200/jco.2006.24.18_suppl.14607